Eli Lilly to expand R&D investment

Eli Lilly and Co. will unveil its plans to increase investment for cancer research in Korea, aiming to take advantage of the country's talented medical scientists and need for new drugs, according to Lilly Korea.

Lilly's executives visited Seoul to attend the World Conference on Lung Cancer, which is being held in Korea for the first time. During the five-day conference, of which Lilly is th...